IndiaInfoline » Markets » BIOCON

Biocon Ltd - Share Price

BIOCON

Open

448.50

Prev. Close

447.90

Turnover (lac.)

13,259

Day's High

448.50

Day's Low

434.30

52 Week's High

478.00

52 Week's Low

235.55

Book Value

64

Face Value

5

Mkt Cap (Cr.)

52,548

P/E

149.37

EPS

2.93

Divi. Yield

0

Biocon LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Biocon LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd483.6538.94116,031.84531.950.832,878.64101.68
Dr Reddys Laboratories Ltd5,058.1525.1583,990.09950.200.493,244.40919.75
Divis Laboratories Ltd3,093.4051.3982,105.45492.250.521,709.96275.61
Cipla Ltd764.0027.5761,594.25610.300.523,035.72215.82
Biocon Ltd437.90149.3752,518.0084.800.00520.7062.80

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Biocon LtdSummary & Reports

Biocon Limited is Indias largest and fully-integrated, innovation-led biopharmaceutical company. Some of its key brands are INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab), KRABEVAA (Bevacizumab) and ALZUMAb (Itolizumab), a first in class anti-CD6 monoclonal antibody. The company has a rich pipeline of Biosimilars and Novel Biologics at various stages of development including Insulin Tregopil, ... More

Registered Office

20th KM Hosur Road Hebbagodi,Electronic City P O,Bangalore, Karnataka,560100

Tell. : +91-80-28082808
Website : http://www.biocon.com
Email : co.secretary@biocon.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

View

- <

Reco. Price

Oct 16,2020 12:49 PM

Target Price

Target Returns:

0.00%

Result Express

Biocon Ltd's Q3FY19 consolidated net profit rises 136.34% yoy to Rs217.20cr : Beats Estimates

Oct 20, 2020 05:54 AM

The company’s consolidated revenue stood at Rs1,540.80cr, up 45.65% yoy and 16.64% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    22 Sep 2020

    Annc. Date

    22 Sep 2020

    With reference to the captioned subject, pursuant to Regulation 30 of SEBI Listing Regulations, we w... More

  • Purpose

    AGM

    Exp. Date

    24 Jul 2020

    Annc. Date

    01 Jul 2020

    AGM 23/07/2020Newspaper Advertisement - Notice - 42nd Annual General Meeting of Biocon Limited to be... More

  • Purpose

    Board Meeting

    Exp. Date

    23 Jul 2020

    Annc. Date

    07 Jul 2020

    BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled o... More